NASDAQ:HOTH
Hoth Therapeutics Inc. Stock News
$1.16
-0.0600 (-4.92%)
At Close: May 28, 2024
LD Micro-Announces Preliminary List of Presenters for the LD 500.
07:34pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Hoth Therapeutics (NASDAQ:HOTH) and Aileron Therapeutics (NASDAQ:ALRN) Head-To-Head Comparison
01:36am, Monday, 03'rd Aug 2020
Hoth Therapeutics (NASDAQ:HOTH) and Aileron Therapeutics (NASDAQ:ALRN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of t
Hoth Therapeutics Executes Licensing Agreement of VNLG-152 for Treatment of Dermatological Diseases
01:08pm, Friday, 31'st Jul 2020
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has executed a licensing agreement with Isoprene Pharmaceuticals, Inc. to acquire the rights to VNLG-152, a nove
Registration - Sidoti's 2020 Fall Virtual Investor Conference is Now Open
08:19pm, Thursday, 30'th Jul 2020
Our Biannual Investor Conference has become a leading forum for small-cap companies to interface with investors specifically interested in the small-cap equities.
Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary
01:26pm, Thursday, 09'th Jul 2020
NEW YORK , July 09, 2020 -- Voltron Therapeutics, Inc. (the Company) announced today it has retained Buenaventura Advisors, LLC to explore strategic alternatives for HaloVax, a.
Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19
12:30pm, Wednesday, 08'th Jul 2020
Voltron Therapeutics, Inc. announced today it has initiated preclinical animal testing of the first construct of its HaloVax Self-Assembling Vaccine (SAV) against COVID-19. Voltron will take two diff
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 1)
AbbVie Inc (NYSE: ABBV)
ADC...
Hoth Therapeutics Announces Sponsored Research Agreement with VCU for Potential COVID-19 Treatment
01:08pm, Tuesday, 30'th Jun 2020
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced entering into a sponsored research agreement with Virginia Commonwealth University (VCU) for a potential COVID-19 t
The
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
12:00am, Thursday, 18'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 17)
Adverum Biotechnologies Inc...
Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company, today announced that it has expanded its sponsored research agreement with the George Washington University (GW) to explore the pote
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Scientific Advisory Board member and inventor of novel peptide COVID-19 therapeutic, Michael H. Peters, Ph.D.,
Wall Street Suggests Buying These 2 Falling Knives
03:43pm, Sunday, 14'th Jun 2020
Their share prices are predicted to bounce back strongly Continue reading...
The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations
12:00am, Friday, 12'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 11)
ADC Therapeutics SA (NYSE:...
Hoth Therapeutics Receives Notice of Allowance for U.S. Patent Regarding Methods for Treating Cancer and Dermatology Conditions
01:08pm, Monday, 08'th Jun 2020
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for US Patent Applicati
